Award recordCONTRACT

KENTUCKY BLOOD CENTER, INC.

PIID 36C24921N0036· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $205,491 net obligations· UEI NEVML7ZDHZC7· KY

Description

BLOOD AND BLOOD PRODUCTS - EXERCISE OPTION YEAR THREE(3) PERIOD OF PERFORMANCE 10/1/20 - 9/30/21

First action · last action
2020-10-01 · 2021-12-14
Transactions
2
First transaction's obligation
$275,000
Base + all options value (sum of deltas)
$205,491
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA24918D20344
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$275,000$0Base award · 2020-10-01 · this action $275,000 · running total $275,000Modification P00001 · 2021-12-14 · this action -$69,509 · running total $205,491
  • Base2020-10-01+$275,000= $275,000
  • Mod P000012021-12-14-$69,509= $205,491
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-10-01+$275,000$275,000BLOOD AND BLOOD PRODUCTS - EXERCISE OPTION YEAR THREE(3) PERIOD OF PERFORMANCE 10/1/20 - 9/30/21
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-12-14−$69,509$205,491BLOOD AND BLOOD PRODUCTS - EXERCISE OPTION YEAR THREE(3) PERIOD OF PERFORMANCE 10/1/20 - 9/30/21

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEVML7ZDHZC7)

AwardOffice · PSC / listingNet obligationsFY
36C24926N0117249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$299,043FY2026
36C24925N0051249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$220,676FY2025
36C24924N0066249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$171,294FY2024
36C24923A0004249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C24923N0116249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$214,347FY2023
36C24922N0027249-NETWORK CONTRACT OFFICE 9 (36C249) · Q508 · MEDICAL- HEMATOLOGY$156,844FY2022

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24921N0036_3600_VA24918D20344_3600 · retrieved 2026-09-26.